Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 48 for “"combinatorial therapy"”.

  1. E6 Inhibtion-Mediated Combinatorial Therapy for HPV+ HNSCC

    … treatment options include chemo- and radiotherapy, though the effectiveness of these therapies is limited by the viral oncoprotein E6, which disrupts apoptotic pathways by binding to and accelerating the degradation of molecules such as p53 and caspase- 8. Our hypothesis was that inhibiting …

    loma-linda Repository record for E6 Inhibtion-Mediated Combinatorial Therapy for HPV+ HNSCC (opens in a new tab)

  2. Efficacy of losartan and growth hormone combinatorial therapy in DyW mice

    … with the MDC1A disease in humans. To this point, therapy development has mainly utilized single-mode therapy. While effective in attenuating some aspects of pathology, no single treatment has been able to completely ameliorate the multi-faceted pathology of laminin-2 deficiency. Therefore this …

    bu Repository record for Efficacy of losartan and growth hormone combinatorial therapy in DyW mice (opens in a new tab)

  3. Immunotoxin Monotherapy and Combinatorial Therapy With Immune Checkpoint Inhibitors for Malignant Brain Tumors

    … of care treatment (surgery, radiation, and chemotherapy) is less than 15 months. Medulloblastoma is another major malignant brain tumor that most frequently occurs in children. Although recent advances in surgery, radiotherapy, and chemotherapy have led to an increase in 5-year survival rates of …

    duke Repository record for Immunotoxin Monotherapy and Combinatorial Therapy With Immune Checkpoint Inhibitors for Malignant Brain Tumors (opens in a new tab)

  4. Combinatorial therapy for triple negative breast cancer and the effect of nanoscale surfaces

    … TNBC pushed the researchers to explore combinatorial therapy regime. A combination of STAT-3 specific inhibitor, reported to act synergistically with metformin in reducing cell growth and inducing apoptosis in TNBCs and agents targeting DNA repair, can produce a new approach to TNBC …

    uiuc Repository record for Combinatorial therapy for triple negative breast cancer and the effect of nanoscale surfaces (opens in a new tab)

  5. EVALUATION OF CELLULAR RESPONSE, RESISTANCE AND COMBINATORIAL THERAPY WITH VINCRISTINE IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

    … leukemia (ALL). This important chemotherapy is extensively used together with glucocorticoids like prednisolone as part of multi-agent chemotherapeutic regimens including our Malaysia-Singapore ALL 2010 treatment protocol. Despite the steady improvements in treatment outcome, around …

    nus Repository record for EVALUATION OF CELLULAR RESPONSE, RESISTANCE AND COMBINATORIAL THERAPY WITH VINCRISTINE IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) (opens in a new tab) Download file for EVALUATION OF CELLULAR RESPONSE, RESISTANCE AND COMBINATORIAL THERAPY WITH VINCRISTINE IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) (opens in a new tab)

  6. Fatty acid synthase 1 in Candida albicans virulence and the in vitro effects of fluconazole, tetracycline in combinatorial therapy

    <p><em>Candida albicans, </em>the causative agent of superficial and invasive mycoses,<em> </em>is a significant fungal pathogen associated with high mortality rates and considerable health-related costs. The most effective class of antifungals used for the treatment of candidiasis includes …

    ut-knoxville Repository record for Fatty acid synthase 1 in Candida albicans virulence and the in vitro effects of fluconazole, tetracycline in combinatorial therapy (opens in a new tab)

  7. Combinatorial Therapy of Doxorubicin and MDR1 SiRNA by Polymeric Micellar Nanoparticles in Treatment of Multidrug Resistance in Breast Cancer

    … effectively treat. Systemically delivered chemotherapy with cytotoxic agents typically requires some convalescence time between treatments – allowing rapidly growing cancer types to develop resistance. Multidrug resistance, also known as pump-dependent, is particularly difficult to treat as it …

    clemson Repository record for Combinatorial Therapy of Doxorubicin and MDR1 SiRNA by Polymeric Micellar Nanoparticles in Treatment of Multidrug Resistance in Breast Cancer (opens in a new tab)

  8. On Boolean Modeling of Gene Regulatory Networks for Improved Cancer Combinatorial Therapy Design and Transcriptome Assemblies for Pacific Whiteleg Shrimp

    … a testable theoretical framework for cancer therapy design which is used to elucidate a role for the metabolism targeting anti-diabetic drug Metformin as part of a combination cocktail therapy that could potentially provide better and less toxic clinical outcomes. Castration-resistant …

    tamu Repository record for On Boolean Modeling of Gene Regulatory Networks for Improved Cancer Combinatorial Therapy Design and Transcriptome Assemblies for Pacific Whiteleg Shrimp (opens in a new tab)

  9. Vascular remodeling is associated with increased permeability of experimental brain metastases of breast cancer

    … decreased efficacy of chemotherapeutics during combinatorial therapy in experimental brain metastases of breast cancer. Lastly, our data point to an exciting novel combination therapy that may significantly decrease the formation of brain metastases of breast cancer.

    ttu Repository record for Vascular remodeling is associated with increased permeability of experimental brain metastases of breast cancer (opens in a new tab)

  10. The Effect Of Oil Palm Phenolics (opp) On Pancreatic Ductal Adenocarcinoma (pdac) In Transgenic Mouse Model

    … and poor treatment outcomes. The use of chemotherapy drug, gemcitabine alone often provides minimal benefits. This study explored the in vivo effect of oil palm phenolics (OPP), a water-soluble extract from oil palm in transgenic mouse model of PDAC and its combination with gemcitabine. …

    wayne-thes Repository record for The Effect Of Oil Palm Phenolics (opp) On Pancreatic Ductal Adenocarcinoma (pdac) In Transgenic Mouse Model (opens in a new tab)

  11. Basis For Targeting Met Activation Mediated Resistance to Pi3K Inhibition In Breast Cancer

    … targeting each pathway, and that combination therapy targeting the PI3K and MET pathway will optimize therapy-effect by preventing the acquisition of resistance. We analyzed cMET and phospho-cMET levels in 257 breast cancer samples and found that high levels of both the proteins were seen in …

    uthsc Repository record for Basis For Targeting Met Activation Mediated Resistance to Pi3K Inhibition In Breast Cancer (opens in a new tab)

  12. COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY

    … sub-population of cells to toxicity, this novel combinatorial therapy of mAb and EMT-reversal orchestrates a selective strategy that enhances cancer cell lethality, for its complete eradication.

    nus Repository record for COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY (opens in a new tab) Download file for COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY (opens in a new tab)

  13. SYNTHESIS AND CHARACTERIZATION OF POLYMERIC MICELLE DELIVERY SYSTEM AS A DRUG AND

    … novel neuron-specific nanotherapeutics for combinatorial therapy of drug and small interfering RNA (siRNA) targeting both extrinsic and intrinsic barriers to neuroplasticity. This neuron-specific polymeric micelle nanotherapeutics will be designed as follows: First, a cell-type specific …

    clemson Repository record for SYNTHESIS AND CHARACTERIZATION OF POLYMERIC MICELLE DELIVERY SYSTEM AS A DRUG AND (opens in a new tab)

  14. HEAT SHOCK PROTEINS AS NOVEL CANCER THERAPEUTICS: TARGETING THE HALLMARKS OF CANCER

    … related to targeting HSPs as a novel anti-tumor therapy. The predominant mechanism of chaperone inhibition is through either disruption of the HSP association with client protein or an altered binding state that ultimately leads to proteasome-mediated degradation. Importantly, chaperone …

    vcu Repository record for HEAT SHOCK PROTEINS AS NOVEL CANCER THERAPEUTICS: TARGETING THE HALLMARKS OF CANCER (opens in a new tab)

  15. FUNCTIONAL DROP-OUT SCREENINGS IDENTIFY ACTIONABLE VULNERABILITIES TO HALT MELANOMA GROWTH AND METASTASIS FORMATION

    … on these results, I identified one promising combinatorial therapy approach, that notably showed remarkable efficacy when tested in vivo. Moreover, in order to specifically investigate the metastatic process, I set up a relevant model of spontaneous metastasis, in which I performed drop-out …

    milano Repository record for FUNCTIONAL DROP-OUT SCREENINGS IDENTIFY ACTIONABLE VULNERABILITIES TO HALT MELANOMA GROWTH AND METASTASIS FORMATION (opens in a new tab)

  16. The Potential of CRL4-DCAF1 and KSR1 as Therapeutic Targets in Low-grade Merlin-Deficient Tumours

    … options are restricted to surgery and radiotherapy, which are invasive and may cause further tumour development. The activity of both the E3 ubiquitin ligase complex Cullin 4 really interesting new gene (RING) E3 ubiquitin ligase- DNA damage binding protein (DDB1) and Cullin 4 associated …

    plymouth Repository record for The Potential of CRL4-DCAF1 and KSR1 as Therapeutic Targets in Low-grade Merlin-Deficient Tumours (opens in a new tab)

  17. Novel protective modifiers in mouse models of spinal muscular atrophy

    … by age 2. SMA is uniquely positioned for therapy, however, as a nearly identical gene called SMN2 can be modulated to express the functional SMN protein. A recently approved, highly efficacious therapy called Spinraza adopts this strategy and has brought promise to the SMA patient …

    missouri Repository record for Novel protective modifiers in mouse models of spinal muscular atrophy (opens in a new tab)

  18. Optimization of Survivin Dimerization Inhibitors for the Treatment of Docetaxel-Resistant Prostate Cancer

    … warranting future in vivo efficacy studies as a combinatorial therapy. Overall, our findings indicate survivin is a significant contributor to docetaxel resistance in metastatic prostate cancer at the molecular level and survivin inhibitors may prove efficacious as a new therapy to sensitize …

    iupui Repository record for Optimization of Survivin Dimerization Inhibitors for the Treatment of Docetaxel-Resistant Prostate Cancer (opens in a new tab)

  19. Identification of Novel Therapeutic Targets and Rational Development of Immunotherapeutics for Recurrent Glioblastoma

    … genetic heterogeneity. Even with surgery, chemotherapy with temozolomide, and radiation, tumor re-growth and patient relapse are inevitable. The extensive inter- and intra-tumoral heterogeneity (ITH) of recurrent GBM emerges from dysregulation at multiple -omic levels of the tumor. ITH exits at …

    mcmaster Repository record for Identification of Novel Therapeutic Targets and Rational Development of Immunotherapeutics for Recurrent Glioblastoma (opens in a new tab)

Page 1 of 3